Home/Filings/4/0001562180-18-001839
4//SEC Filing

Kanes Stephen 4

Accession 0001562180-18-001839

CIK 0001597553other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:13 PM ET

Size

5.7 KB

Accession

0001562180-18-001839

Insider Transaction Report

Form 4
Period: 2018-04-02
Kanes Stephen
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-04-02+27,00027,000 total
    Exercise: $145.77Exp: 2028-04-02Common Stock (27,000 underlying)
Footnotes (1)
  • [F1]The securities awarded on 4/2/2018 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 3,375 shares of common stock shall vest on the one year anniversary of the 2/1/2018 Vesting Start Date with 10,125 shares vesting in 36 equal monthly installments thereafter. Options to purchase 13,500 shares of common stock shall vest periodically upon the Company achieving certain milestones.

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1
  • filerCIK 0001612859

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:13 PM ET
Size
5.7 KB